Dataset from A Phase 2 Study Of SU011248 In The Treatment Of Patients With Bevacizumab-Refractory Metastatic Renal Cell Carcinoma
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/00006803
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to test whether sunitinib (SU011248) has activity and is safe in
patients with renal cell carcinoma (RCC) who have failed prior therapy with bevacizumab
(Avastin) -based treatment.
创建时间：
2025-07-07
